155 related articles for article (PubMed ID: 26019430)
1. Limbic encephalitis with antibodies to glutamic acid decarboxylase presenting with brainstem symptoms.
Incecik F; Hergüner OM; Yıldızdaş D; Horoz O; Besen S
Ann Indian Acad Neurol; 2015; 18(2):243-5. PubMed ID: 26019430
[TBL] [Abstract][Full Text] [Related]
2. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.
Matà S; Muscas GC; Naldi I; Rosati E; Paladini S; Cruciatti B; Bisulli F; Paganini M; Mazzi G; Sorbi S; Tinuper P
J Neuroimmunol; 2008 Aug; 199(1-2):155-9. PubMed ID: 18586329
[TBL] [Abstract][Full Text] [Related]
3. A Survival Case of Super-refractory Status Epilepticus due to Glutamic Acid Decarboxylase Antibodies-associated Limbic Encephalitis.
Liu B; Zhou Y; Meng L; Skinner H
Cureus; 2018 Aug; 10(8):e3125. PubMed ID: 30345184
[TBL] [Abstract][Full Text] [Related]
4. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review.
Vrillon A; Carle G; Berzero G; Honnorat J; Huberfeld G; Psimaras D; Azuar C
Neurosci Biobehav Rev; 2020 Dec; 119():128-137. PubMed ID: 33022299
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.
Mazzi G; Roia DD; Cruciatti B; Matà S; Catapano R
Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013
[TBL] [Abstract][Full Text] [Related]
7. Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies.
Herard K; Khanni JL; Alusma-Hibbert K; Samuels CR; Espinosa PS
Cureus; 2019 May; 11(5):e4738. PubMed ID: 31355097
[TBL] [Abstract][Full Text] [Related]
8. Acute amnesia and seizures in a young female.
García García ME; Castrillo SM; Morales IG; Di Capua Sacoto D; Dolado AM
Epileptic Disord; 2013 Dec; 15(4):455-60. PubMed ID: 24165308
[TBL] [Abstract][Full Text] [Related]
9. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases.
Mishra N; Rodan LH; Nita DA; Gresa-Arribas N; Kobayashi J; Benseler SM
J Child Neurol; 2014 May; 29(5):677-83. PubMed ID: 24092895
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Ren C; Ren H; Ren X; Zhang W; Li J; Dai L; Guan H; Fang F
Front Neurol; 2021; 12():641024. PubMed ID: 33912125
[No Abstract] [Full Text] [Related]
11. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.
Markakis I; Alexopoulos H; Poulopoulou C; Akrivou S; Papathanasiou A; Katsiva V; Lyrakos G; Gekas G; Dalakas MC
J Neurol Sci; 2014 Aug; 343(1-2):192-4. PubMed ID: 24950904
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
16. Anti-glutamic acid decarboxylase antibody screening in first-episode psychosis.
Warren N; Freier K; Siskind D; O'Gorman C; Blum S; Gillis D; Scott JG
Aust N Z J Psychiatry; 2023 Apr; 57(4):603-612. PubMed ID: 35362325
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: a case series.
Incecik F; Herguner OM; Besen S; Yılmaz M
Acta Neurol Belg; 2018 Sep; 118(3):411-414. PubMed ID: 29349679
[TBL] [Abstract][Full Text] [Related]
18. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.
Sharma CM; Pandey RK; Kumawat BL; Khandelwal D; Gandhi P
Ann Indian Acad Neurol; 2016; 19(1):146-9. PubMed ID: 27011652
[TBL] [Abstract][Full Text] [Related]
19. Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy.
Jaafar F; Haddad L; Koleilat N; Sharara-Chami R; Shbarou R
Epilepsy Behav Rep; 2020; 14():100396. PubMed ID: 33305253
[TBL] [Abstract][Full Text] [Related]
20. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
